PCA (OTC:PCRDF) Stock, Quote.Headers.trade-ideas

PCA Corp develops and sells computer software.

PCA Corp

It's easy to feel like the sky is falling when you're watching your retirement savings fluctuate. But emotions and money rarely mix well. That's the situation Jesse, a 61-year-old looking to retire soon, found himself in when he wrote to personal <a href="https://www.benzinga.com/news/25/01/42933027/thats-not-leadership-thats-pissing-on-people-dave-ramsey-shares-what-he-and-famous-nintendo-ceo-have-in-common">finance expert Dave Ramsey</a>.&nbsp;
His letter, published on Ramsey Solutions in May 2023, was filled with panic: "I'm watching my retirement savings completely eroding away day after day. The only place I'm not losing money is $180,000 I have sitting in the bank earning almost zero interest. What should I do?"
Don't Miss:
<ul>
<li><a href="https://www.benzinga.com/money/62-years-old-with-1-mil-saved">I&#8217;m 62 Years Old And Have $1.2 Million Saved. Is This Enough to Retire Stress-Free?</a></li>
<li>Can you guess how many Americans successfully retire with $1,000,000 saved?<a href="https://www.benzinga.com/money/1milsaved"> The percentage may shock you</a>.</li>
</ul>
Dave's response? Let's just say it didn't come with much hand-holding. "Come on, man. ‘Completely eroding away day after day?' That's a little dramatic," Dave shot back. He didn't stop there. Ramsey pulled no punches as he called out the "drama queen" living in Jesse's head: "One of the things you have to understand is we all have a drama queen living in our brain that exaggerates things – especially when it comes to investing. So, take a deep breath and calm down. Everything's going to be okay."
That might sound harsh, but Dave's advice came with a <a href="https://www.benzinga.com/personal-finance/24/12/42691699/i-dont-borrow-money-says-dave-ramsey-even-if-the-offer-is-1-billion-at-0-interest-for-the-next-decade">dose of tough love and facts</a>. He explained that our brains tend to amplify negative financial experiences. "Studies have shown it takes $3 of gain to emotionally offset $1 of loss," he said. "Your investments may be down a little. If you've got $1 million in there, it may be worth $900,000 right now. Next year, it's liable to bounce up to $1.1 million."
See Also: With 100+ historic trademarks including some of the high grossing characters in history, like Cinderella, Snow White and Peter Pan, <a href="https://www.benzinga.com/money/elf-labs-1">this company is transforming the $2 trillion entertainment market with patented AR, VR, and AI tech. — For a short window, investors are able to claim $2/share ($980 min).</a>
In classic Ramsey fashion, he also addressed a common misconception: the fear of losing everything in the stock market. "Have you ever heard people say they lost all their money in the stock market? Well, that's mathematically impossible," he said, unless you put all your money into a single stock that went completely bust. The real culprit, he explained, is panicking and pulling money out at the worst possible time.
So, what's the takeaway here? Jesse, like many nearing retirement, is letting emotions drive decisions. That's understandable, but it's also risky. Markets have always been volatile and yes, there will be down years – but as Dave pointed out, every down year in the last two decades has been followed by two years of record gains. The key is to ride the wave and trust in long-term growth rather than reacting impulsively.
Trending: Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.26/share!</a>
Of course, Dave's "shut up and invest" attitude might not be for everyone. Some might argue that for someone like Jesse, who's close to retirement, it's not unreasonable to want more stability. Diversifying into lower-risk investments or <a href="https://www.benzinga.com/personal-finance/24/06/39360926/diversification-thats-for-idiots-mark-cuban-slams-warren-buffetts-investment-strategy-i-think-bu">adjusting asset allocations</a> might bring peace of mind, even if it means potentially lower returns.
For readers in Jesse's shoes, this is where a <a href="https://www.benzinga.com/money/are-you-rich">financial advisor</a> can be a game-changer. A professional can help evaluate your portfolio, guide you through the emotional rollercoaster and craft a retirement strategy tailored to your specific needs. Sometimes, just having someone to remind you to breathe (and not hit the panic button) is worth its weight in gold.
Read Next:
<ul>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
<li><a href="https://www.benzinga.com/money/suze-orman-retirement-bucket">&#8216;Which Bucket Do I Draw From First?&#8217; Suze Orman Explains To 67-Year-Old The Best Order For Tapping Into Her Retirement Accounts</a></li>
</ul>

Personal Finance

'I'm Watching My Retirement Savings Erode Away!' – 61-Year-Old Panics Over His Investments But Dave Ramsey Tells Him 'Shut Up And Invest'

Cryptocurrency markets are seeing gains across the board despite <a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42969737/bitcoin-rebounds-to-96500-defies-284m-etf-outflows-heres-what-experts-see-happening-next">ongoing ETF outflows</a>, indicating underlying strength in the market. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$96,344.48</td>
<td>+4.7%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$3,201.80</td>
<td>+6.2%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$186.30</td>
<td>+5.2%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.65</td>
<td>+7.9%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.3527</td>
<td>+8.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00002138</td>
<td>+5.5%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul>
<li>IntoTheBlock data shows large transaction volume increasing by 34.7% and daily active addresses up by 4.5%. Transactions greater than $100,000 are up from 6,648 to 10,421 in a single day. Exchanges netflows are down by 332.2%.</li>
<li>Coinglass data reports 78,239 traders were liquidated in the past 24 hours with the total liquidations at $279.24 million.</li>
</ul>
Notable Developments:
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42962279/trump-could-sign-crypto-related-executive-orders-on-day-1-report">Trump Could Sign Crypto-Related Executive Orders On Day 1: Report</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42973211/solana-xrp-etfs-could-outperform-ethereum-etfs-says-jpmorgan">Solana, XRP ETFs Could Outperform Ethereum ETFs, Says JPMorgan</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42985098/gary-gensler-defends-sec-legacy-we-focused-on-reforms-in-the-60-trillion-equity-markets">Gary Gensler Defends SEC Legacy: &#8216;We Focused On Reforms In The $60 Trillion Equity Markets&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42967020/coinbase-wins-partial-victory-in-sec-regulatory-challenge-court-calls-agencys-stance-arbitrary">Coinbase Wins Partial Victory In SEC Regulatory Challenge, Court Calls Agency&#8217;s Stance &#8216;Arbitrary&#8217;</a></li>
</ul>
Top Gainers:
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Ai16z (CRYPTO: AI16Z)</td>
<td> $1.28</td>
<td>+27.4%</td>
</tr>
<tr>
<td>Kaspa (CRYPTO: KAS) </td>
<td> $0.1366</td>
<td>+21.2%</td>
</tr>
<tr>
<td>Virtuals Protocol (CRYPTO: VIRTUAL)</td>
<td> $2.97  </td>
<td>+20.7%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: With Bitcoin prices continuing its uptrend, crypto trader Jelle noted that it is moving as expected. 
He believes things will look much better after $97,000.
Echoing similar sentiment, crypto trader Mayne termed this as a nice move after a run of the lows. 
While awaiting CPI data, he recommends flipping the midrange level to maintain the upward push.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Nice move after a run of the lows. Breaker set up potential here. Flip the midrange and I think we continue to push higher. CPI tmrw so let&#39;s see <a href="https://t.co/r5asjbtYGI">pic.twitter.com/r5asjbtYGI</a>
&mdash; Mayne (@Tradermayne) <a href="https://twitter.com/Tradermayne/status/1879203603925336507?ref_src=twsrc%5Etfw">January 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader EliZ <a href="https://x.com/eliz883/status/1879234052626264216">notes</a> Bitcoin has reached a critical trigger point but highlights indecision in the market.
 He advises adjusting stops to breakeven for active positions.
More Crypto Online explained that the recent upside move could indicate a potential bottom if the price holds above $94,244, with an ideal next high reaching at least $97,995.
 The pattern resembles the lead-up to the January 6th top but appears weaker.
The rally began from a favorable location, increasing the chances of a low being established yesterday. 
A confirmed upside reversal requires the price to form and hold a higher low in a subsequent wave 2.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a>: While the move to the upside from yesterday&#39;s low may visually look like a 5-wave pattern, based on fibonacci guidelines one more high would be ideal. This one more high should reach at least $97,995 and I am going to watch for one more high as long as the price holds above… <a href="https://t.co/TTFUWlXJWU">pic.twitter.com/TTFUWlXJWU</a>
&mdash; More Crypto Online (@Morecryptoonl) <a href="https://twitter.com/Morecryptoonl/status/1879186940039160197?ref_src=twsrc%5Etfw">January 14, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/01/42957400/bitcoins-big-macro-data-week-heres-what-to-watch">Bitcoin&#8217;s Big Macro Data Week: Here&#8217;s What To Watch</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

$BTC

$DOGE

$ETH

$SHIB

$SOL

$XRP

Bitcoin, Ethereum, XRP, Dogecoin Move Higher Ahead Of Inflation Data Wednesday

Meiwu Technology Company Halted On A Circuit Breaker To The Downside, Stock Now Down 25%

Meiwu Technology Company Shares Resume Trading

Meiwu Technology Company Shares Halted On A Circuit Breaker To The Downside, Stock Now Down 13.3%

<a href="https://www.bloomberg.com/news/articles/2025-01-14/citigroup-reduces-its-401-k-contributions-for-highest-earners?sref=ZoyErlU1" title="https://www.bloomberg.com/news/articles/2025-01-14/citigroup-reduces-its-401-k-contributions-for-highest-earners?sref=ZoyErlU1">https://www.bloomberg.com/news/articles/2025-01-14/citigroup-reduces-its-401-k-contributions-for-highest-earners?sref=ZoyErlU1</a>

"Citigroup Is Shrinking How Much It Pays Into The Retirement Funds Of Its Highest-Earning Employees In The US" -Bloomberg Report

In the current market session, Clorox Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLX#NYSE">CLX</a>) share price is at $158.44, after a 0.62% spike. Moreover, over the past month, the stock fell by 2.93%, but in the past year, went up by 9.97%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1736885713_0.png" alt="Past Year Chart" />

<h3>Evaluating Clorox P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Clorox has a better P/E ratio of 54.68 than the aggregate P/E ratio of 29.17 of the Household Products industry. Ideally, one might believe that Clorox Inc. might perform better in the future than it's industry group, but it's probable that the stock is overvalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1736885713_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

P/E Ratio Insights for Clorox

Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) has outperformed the market over the past 15 years by 13.52% on an annualized basis producing an average annual return of 24.99%. Currently, Tyler Technologies has a market capitalization of $24.05 billion. 
Buying $1000 In TYL: If an investor had bought $1000 of TYL stock 15 years ago, it would be worth $27,541.67 today based on a price of $562.01 for TYL at the time of writing.
<h3>Tyler Technologies's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736885712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today

Bank of America has identified three key auto stocks it expects to outperform in 2025: Ferrari PLC (RACE), Aptiv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APTV#NYSE">APTV</a>) and AutoNation Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AN#NYSE">AN</a>). The firm notes that these companies are well-positioned to benefit from ongoing <a href="https://www.benzinga.com/news/contracts/25/01/42879460/honda-amazon-collaborate-on-ev-development-with-generative-ai-and-iot">trends in the automotive industry</a>, despite recent volatility and sector-specific challenges.
Ferrari (RACE): Resilient Luxury and Brand Power
Ferrari&#8217;s shares increased by 26% in 2024, climbing from $338 at the end of 2023 to $425 by the close of 2024. Bank of America analysts maintain a &#8220;Buy&#8221; rating on Ferrari, emphasizing its positioning as a luxury automaker with significant brand value. The company&#8217;s strategy of balancing restrained production growth, price increases and new model rollouts is expected to sustain consistent revenue and earnings growth.
The launch of the F80 in late 2025 and the HyperCar in late 2026 are anticipated to enhance Ferrari&#8217;s product mix, alongside improvements in its racing performance. The firm highlights Ferrari&#8217;s ability to differentiate its vehicles and maintain operational efficiency, noting that its financial outlook remains conservative. Analysts believe Ferrari&#8217;s earnings resilience in uncertain macroeconomic conditions is a key strength that will drive its stock performance in the coming year.
Aptiv (APTV): Positioned for a Rebound Aptiv saw its stock price fall 33%, from $90 at the end of 2023 to $60 by the end of 2024. Despite this drop, Bank of America analysts see a recovery opportunity and maintain a &#8220;Buy&#8221; rating on the stock. The decline was primarily driven by a slowdown in EV sales, increased competition from Chinese automakers, and reduced production volumes among key customers.
However, analysts at BofA argue that these headwinds are temporary. The company&#8217;s expertise in vehicle architecture and connectivity aligns with automakers&#8217; efforts to simplify manufacturing processes. Bank of America expects Aptiv's growth rate to reaccelerate between 2026 and 2027, leading to stronger earnings and valuation recovery.
AutoNation (AN): Capitalizing on Industry Momentum AutoNation&#8217;s stock gained 13% in 2024, rising from $150 to $170. Bank of America analysts view the company favorably, citing its structural improvements since the pandemic and its ability to generate strong free cash flow. This financial strength enables AutoNation to reinvest in business initiatives, buy back shares and benefit from the ongoing recovery in U.S. new vehicle sales.
The analysts expect that new vehicle gross profit per unit will stabilize at elevated levels by the end of 2025 or 2026, supporting AutoNation&#8217;s earnings momentum. Furthermore, the company's SG&amp;A leverage is expected to remain strong. Despite these positives, AutoNation is trading at a discount compared to its historical average and its peers, with a next-12-month price-to-earnings ratio of approximately 9.2x versus a historical average of 13x. Analysts believe this undervaluation provides a compelling investment case.
Sector-Wide Insights: Bank of America notes that vehicle payments as a percentage of disposable income are within affordable levels, while both new and used vehicle prices have stabilized. The constrained supply of late-model used vehicles should further support pricing. Analysts also highlight the necessity for consolidation within the automotive industry, given challenges like overcapacity and the transition to electric and autonomous vehicles.
The firm predicts that autonomous vehicle progress will drive the need for federal regulatory frameworks to streamline development and deployment. This regulatory clarity could help foster broader adoption of the technology.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/01/42985789/starbucks-shines-qsr-faces-challenges-bofas-2025-restaurant-outlook">Starbucks Shines, QSR Faces Challenges: BofA&#8217;s 2025 Restaurant Outlook</a></li>
</ul>
Image via Flickr.

Movers

APTV

RACE

TSLA

Bank of America Highlights Ferrari, Aptiv and AutoNation as Top Auto Stocks for 2025

<a href="https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html" title="https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html">https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html</a>
<a href="https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html" title="https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html">https://www.cnbc.com/2025/01/14/microsoft-pauses-hiring-in-us-consulting-unit-memo-says.html</a>

MSFT

"Microsoft Plans To Pause Hiring In Part Of Its Consulting Business In The U.S. According To An Internal Memo, As The Company Seeks Ways to Reel In Expenses" -CNBC Report

Investors love high-growth stories, and they should.
Companies that are growing rapidly have the potential to deliver massive gains.
The problem is that Wall Street and most observers are not always using the right metrics to determine growth.
The most used metric is earnings per share growth. Nothing excites people more than a massive year-over-year earnings gain.
Once you have been at this for a while, you realize that a competent accountant can make the earnings per share numbers be almost anything their boss wants them to be.
Earnings management and even outright fraud can go on for longer than one would think.
Just as with people who bought into Enron, WorldCom, or any other companies that were Wall Street darlings until the ugly truth was revealed.
Many companies have been accused of other forms of accounting misconduct that led investors down a primrose path over the years, including stalwarts like Kraft Heinz (Ticker: KHC), Chemours Chemical (Ticker: CC) (Teflon manufacturer), and Archer Daniels Midland (Ticker: ADM), which have been accused of irregularities that made things look better than they were.
I tend to ignore reported earnings most of the time.
One of the greatest lessons I have learned over the years is that everything eventually shows up on the balance sheet.
I like to look at top-line revenue growth and then skip everything in between to look at book value growth.
This allows me to see what happens once management gets their hands on the money.
Did they use the cash wisely and invest the excess cash flow to increase the company&#8217;s value?
Or did they waste it and not create much value along the way?
If you want to see this theory in action, the three companies with the fastest book value growth in the S&amp;P 500(Ticker: SPY) are NVIDIA (Ticker: NVDA), Amazon (Ticker: AMZN), and Tesla (Ticker: TSLA).
Management received the cash, paid the bills, and grew the value of the business.
In this case, it does not matter what the price-to-book ratio value is.
We are not measuring valuations.
We are simply determining if management is converting revenues to real value at a high rate.
It is no accident that Warren Buffett has measured his success at Berkshire Hathaway (BRK.A) by the growth in book value.
It is the best way to measure growth.
Very few people look at stocks this way, so we can use the combination of revenue and book value growth to find some potential gems that are well under Wall Street&#8217;s radar.
Velocity Financial (Ticker: VEL) is a business that is perfectly positioned to take advantage of the housing affordability crisis.
Thanks to higher mortgage rates and a lack of inventory, people are renting for longer.
Velocity Financial (VEL) operates in an often-overlooked but highly lucrative niche of the real estate finance world, specializing in loans for real estate investors. This is not your typical Fannie Mae or Freddie Mac lending operation; Velocity thrives in the non-QM (non-qualified mortgage) space, targeting small- to mid-sized investors who need financing for rental properties and small commercial ventures. This is the bread and butter of the real estate world—the individuals who are rehabbing houses, growing rental portfolios, and breathing life into small business properties.
Velocity is not competing with big banks or institutions chasing the cookie-cutter borrower. Instead, it is laser-focused on a niche that is too small for the big institutions to care about but too complex for the smaller entities to handle. It offers tailored financing for single-family rentals, small multifamily properties, and even small commercial buildings like retail or mixed-use spaces. Borrowers are often small investors with solid property cash flow but not the financial profile big banks want to consider.
The loans are short- to medium-term, high-yield, and relatively low balance, which means Velocity captures some attractive interest income compared to traditional lenders. Velocity has built a scalable origination platform, using brokers and direct relationships to keep the deals flowing while maintaining tight underwriting standards. Their proprietary process focuses on the property&#8217;s cash flow, an approach that fits this market perfectly.
The business is growing impressively.
Revenue is growing at over 20% annually, and tangible book value has grown by about 25% over the past five years.
Given the niche market Velocity serves, I would expect the company to continue to grow at an above-average rate for several years. As Wall Street discovers this company, we could see buying pressure push the stock to much higher prices in the years ahead.
Red Violet, Inc. (Ticker: RDVT) is one of those under-the-radar plays that quietly builds an impressive moat in a high-growth niche. At its core, this is a data and technology company with a focus on identity intelligence and data fusion. In simpler terms, Red Violet takes massive amounts of data, turns it into actionable insights, and sells it to industries that need help solving some of their biggest problems—fraud, compliance, risk, and verification.
This is the kind of company that thrives in today&#8217;s data-driven world. It is not flashy, but it is indispensable to its customers. Red Violet operates through two key platforms: IDI Core and Forewarn, both of which are designed to make the complex world of data analytics simple and accessible for its users.
IDI Core is the workhorse of the operation. This platform is used by a variety of industries—financial services, insurance, government, legal—to verify identities, detect fraud, and conduct investigations. Think of it as the Swiss Army knife for anyone needing to sift through mountains of data quickly and accurately. It is the platform that makes businesses smarter, faster, and more compliant in an increasingly regulated world.
Then there is Forewarn, which takes a different tack by focusing on the real estate industry. Real estate agents use this tool to screen potential clients and assess risks instantly. With safety concerns on the rise in the field, Forewarn has carved out a strong niche in a growing vertical.
What sets Red Violet apart is its proprietary technology. They have built a scalable infrastructure capable of analyzing billions of records and turning them into something useful.
That is not just tech buzz. It is the foundation for why customers keep coming back and why the company&#8217;s business model works.
Sales and earnings are both growing at around 30% a year and have the potential to continue to grow at a very high rate.
As the dollars come in the door, Red Violet Management is using them to increase the value of the company at a rapid pace.

Opinion

AMZN

NVDA

RDVT

Under the Radar: The Importance of Book Value Growth in Assessing Company Stability

Starwood Prop Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STWD#NYSE">STWD</a>) underwent analysis by 4 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $21.25, a high estimate of $23.00, and a low estimate of $20.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 1.71%. 
<img src="https://www.benzinga.com/files/images/story/2025/1736884865_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Starwood Prop Trust. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jade Rahmani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$22.00</td>
<td>$22.50</td>
</tr>
<tr>
<td>Douglas Harter</td>
<td>UBS</td>
<td>Raises</td>
<td>Neutral</td>
<td>$20.00</td>
<td>$19.50</td>
</tr>
<tr>
<td>Steven Delaney</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$23.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$20.00</td>
<td>$20.50</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Starwood Prop Trust. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Starwood Prop Trust compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Starwood Prop Trust's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Starwood Prop Trust's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/STWD/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Starwood Prop Trust analyst ratings.</a>
<h2>Get to Know Starwood Prop Trust Better</h2>
Starwood Property Trust Inc is an American real estate investment trust principally engaged in originating, acquiring, and managing commercial mortgage loans and commercial mortgage-backed securities in the U.S. and Europe. The company organizes its activities into Commercial and Residential Lending Segment, Infrastructure Lending Segment, Property Segment and Investing and Servicing Segment. The company generates the majority of its revenue from the Real estate commercial and residential lending segment, which is engaged in originating, acquiring, financing, and managing commercial first mortgages, and non-agency residential mortgages.
<h3>Unraveling the Financial Story of Starwood Prop Trust</h3>
Market Capitalization: Boasting an elevated market capitalization, the company surpasses industry averages. This signals substantial size and strong market recognition.
Revenue Growth: Starwood Prop Trust displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 53.5%. This indicates a notable increase in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Starwood Prop Trust's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 31.76%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): Starwood Prop Trust's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 1.17%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Starwood Prop Trust's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of 0.12%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 1.34, Starwood Prop Trust adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

STWD

Where Starwood Prop Trust Stands With Analysts

Providing a diverse range of perspectives from bullish to bearish, 6 analysts have published ratings on Hartford Finl Servs Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIG#NYSE">HIG</a>) in the last three months.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $134.17, a high estimate of $141.00, and a low estimate of $125.00. This upward trend is apparent, with the current average reflecting a 6.76% increase from the previous average price target of $125.67.
<img src="https://www.benzinga.com/files/images/story/2025/1736884854_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
A comprehensive examination of how financial experts perceive Hartford Finl Servs Gr is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$130.00</td>
<td>$134.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$139.00</td>
<td>$135.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Raises</td>
<td>Overweight</td>
<td>$135.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Michael Zaremski</td>
<td>BMO Capital</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$141.00</td>
<td>$100.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$135.00</td>
<td>$133.00</td>
</tr>
<tr>
<td>Jimmy Bhullar</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Neutral</td>
<td>$125.00</td>
<td>$122.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Hartford Finl Servs Gr. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Hartford Finl Servs Gr compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Hartford Finl Servs Gr's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Hartford Finl Servs Gr's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/HIG/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Hartford Finl Servs Gr analyst ratings.</a>
<h2>All You Need to Know About Hartford Finl Servs Gr</h2>
The Hartford Financial Services Group Inc offers a diverse range of property and casualty insurance, group benefits, and mutual fund services to a customer base of individuals and corporations. It operates in five segments: Commercial Lines, Personal Lines, Property &amp; Casualty Other Operations, Group Benefits, and Hartford Funds, as well as a Corporate category.
<h3>Hartford Finl Servs Gr's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Positive Revenue Trend: Examining Hartford Finl Servs Gr's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 10.05% as of 30 September, 2024, showcasing a substantial increase in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Hartford Finl Servs Gr's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 11.33%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Hartford Finl Servs Gr's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.75%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Hartford Finl Servs Gr's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.95%, the company may face hurdles in achieving optimal financial returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.26.
<h2>The Significance of Analyst Ratings Explained</h2>
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter. 
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Glimpse Into The Expert Outlook On Hartford Finl Servs Gr Through 6 Analysts

Payoneer Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAYO#NASDAQ">PAYO</a>) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">3</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $12.3, a high estimate of $14.00, and a low estimate of $10.00. Surpassing the previous average price target of $10.25, the current average has increased by 20.0%.
<img src="https://www.benzinga.com/files/images/story/2025/1736884846_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
A clear picture of Payoneer Global's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Ashwin Shirvaikar</td>
<td>Citigroup</td>
<td>Raises</td>
<td>Buy</td>
<td>$13.00</td>
<td>$8.50</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$11.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Maintains</td>
<td>Market Perform</td>
<td>$12.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Mike Grondahl</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$14.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Mike Grondahl</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$13.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Will Nance</td>
<td>Goldman Sachs</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Sanjay Sakhrani</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Raises</td>
<td>Outperform</td>
<td>$12.00</td>
<td>$9.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$12.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Raises</td>
<td>Buy</td>
<td>$14.00</td>
<td>$10.00</td>
</tr>
<tr>
<td>Mark Palmer</td>
<td>Benchmark</td>
<td>Raises</td>
<td>Buy</td>
<td>$10.00</td>
<td>$9.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Payoneer Global. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Payoneer Global compared to the broader market.</li>
<li>Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Payoneer Global's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Payoneer Global's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/PAYO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Payoneer Global analyst ratings.</a>
<h2>Discovering Payoneer Global: A Closer Look</h2>
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started to empower global commerce by connecting businesses, professionals, countries, and currencies with its diversified cross-border payments platform.
<h3>Key Indicators: Payoneer Global's Financial Health</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Revenue Growth: Payoneer Global's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 19.34%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Financials sector.
Net Margin: Payoneer Global's net margin is impressive, surpassing industry averages. With a net margin of 16.75%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): Payoneer Global's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 5.95%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Payoneer Global's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of 0.6%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a below-average debt-to-equity ratio of 0.05, Payoneer Global adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PAYO

Expert Outlook: Payoneer Global Through The Eyes Of 10 Analysts

13 analysts have shared their evaluations of Evolent Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVH#NYSE">EVH</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">5</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">2</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Evolent Health and provided 12-month price targets. The average target is $21.08, accompanied by a high estimate of $34.00 and a low estimate of $15.00. A decline of 32.39% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1736884839_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Evolent Health is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$17.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Jailendra Singh</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$20.00</td>
<td>$24.00</td>
</tr>
<tr>
<td>Daniel Grosslight</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$18.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Constantine Davides</td>
<td>JMP Securities</td>
<td>Lowers</td>
<td>Market Outperform</td>
<td>$18.00</td>
<td>$27.00</td>
</tr>
<tr>
<td>Matthew Sheerin</td>
<td>Needham</td>
<td>Announces</td>
<td>Buy</td>
<td>$15.00</td>
<td>-</td>
</tr>
<tr>
<td>Anne Samuel</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$15.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Jeff Jones</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Daniel Grosslight</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$21.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Sean Dodge</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Stephanie Davis</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$19.00</td>
<td>$39.00</td>
</tr>
<tr>
<td>Jeff Jones</td>
<td>Oppenheimer</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$34.00</td>
<td>$45.00</td>
</tr>
<tr>
<td>Jeff Garro</td>
<td>Stephens &amp; Co.</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$16.00</td>
<td>-</td>
</tr>
<tr>
<td>Daniel Grosslight</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$33.00</td>
<td>$35.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Evolent Health. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Evolent Health compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Evolent Health's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Evolent Health's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/EVH/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Evolent Health analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>About Evolent Health</h2>
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
<h3>Evolent Health's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Over the 3 months period, Evolent Health showcased positive performance, achieving a revenue growth rate of 21.6% as of 30 September, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.
Net Margin: Evolent Health's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -5.03% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Evolent Health's ROE stands out, surpassing industry averages. With an impressive ROE of -2.99%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): Evolent Health's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -1.26% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: With a below-average debt-to-equity ratio of 0.61, Evolent Health adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>What Are Analyst Ratings?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What Analysts Are Saying About Evolent Health Stock

Investors with a lot of money to spend have taken a bearish stance on Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with GOOGL, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://pro.benzinga.com/?utm_source=insights">Benzinga</a>'s options scanner spotted 124 uncommon options trades for Alphabet.
This isn't normal.
The overall sentiment of these big-money traders is split between 36% bullish and 44%, bearish.
Out of all of the special options we uncovered, 46 are puts, for a total amount of $3,433,962, and 78 are calls, for a total amount of $7,581,492.
<h3>Projected Price Targets</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $25.0 to $350.0 for Alphabet over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Alphabet's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Alphabet's substantial trades, within a strike price spectrum from $25.0 to $350.0 over the preceding 30 days.
<h3>Alphabet Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736884836_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$27.1</td>
<td>$26.8</td>
<td>$26.83</td>
<td>$180.00</td>
<td>$2.6M</td>
<td>1.0K</td>
<td>1.0K</td>
</tr>
<tr>
<td>GOOGL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$13.55</td>
<td>$13.4</td>
<td>$13.46</td>
<td>$190.00</td>
<td>$807.6K</td>
<td>1.6K</td>
<td>610</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$11.9</td>
<td>$11.8</td>
<td>$11.8</td>
<td>$200.00</td>
<td>$588.8K</td>
<td>20.1K</td>
<td>881</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$30.65</td>
<td>$30.35</td>
<td>$30.5</td>
<td>$160.00</td>
<td>$228.7K</td>
<td>19.5K</td>
<td>370</td>
</tr>
<tr>
<td>GOOGL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$11.9</td>
<td>$11.75</td>
<td>$11.8</td>
<td>$200.00</td>
<td>$208.8K</td>
<td>20.1K</td>
<td>1.0K</td>
</tr>
</tbody>
</table>

<h3>About Alphabet</h3>
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV, YouTube Music among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform, or GCP, accounts for roughly 10% of Alphabet's revenue with the firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) making up the rest.
Having examined the options trading patterns of Alphabet, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Alphabet's Current Market Status</h3>
<ul>
<li>With a volume of 8,829,015, the price of GOOGL is up 0.12% at $191.24. </li>
<li>RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
<h3>Expert Opinions on Alphabet</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $222.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Wedbush has decided to maintain their Outperform rating on Alphabet, which currently sits at a price target of $220. 
&#x2A; An analyst from Keybanc has decided to maintain their Overweight rating on Alphabet, which currently sits at a price target of $225. 
&#x2A; An analyst from Stifel has decided to maintain their Buy rating on Alphabet, which currently sits at a price target of $225. 
&#x2A; An analyst from Wolfe Research persists with their Outperform rating on Alphabet, maintaining a target price of $230. 
&#x2A; Consistent in their evaluation, an analyst from B of A Securities keeps a Buy rating on Alphabet with a target price of $210. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Alphabet, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

GOOGL

Unpacking the Latest Options Trading Trends in Alphabet

Investors with a lot of money to spend have taken a bullish stance on Core Scientific (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CORZ#NASDAQ">CORZ</a>).
And retail traders should know.
We noticed this today when the positions showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with CORZ, it often means somebody knows something is about to happen.
Today, Benzinga's options scanner spotted 12 options trades for Core Scientific.
This isn't normal.
The overall sentiment of these big-money traders is split between 58% bullish and 41%, bearish.
Out of all of the options we uncovered, there was 1 put, for a total amount of $63,625, and 11, calls, for a total amount of $488,587.
<h3>What's The Price Target?</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $8.0 and $17.0 for Core Scientific, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Core Scientific's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Core Scientific's substantial trades, within a strike price spectrum from $8.0 to $17.0 over the preceding 30 days.
<h3>Core Scientific Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736884831_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$1.92</td>
<td>$1.91</td>
<td>$1.92</td>
<td>$17.00</td>
<td>$96.0K</td>
<td>4.2K</td>
<td>1.0K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$8.55</td>
<td>$8.45</td>
<td>$8.45</td>
<td>$8.00</td>
<td>$66.7K</td>
<td>4.9K</td>
<td>489</td>
</tr>
<tr>
<td>CORZ</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$2.6</td>
<td>$2.42</td>
<td>$2.56</td>
<td>$12.00</td>
<td>$63.6K</td>
<td>1.0K</td>
<td>250</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.0</td>
<td>$7.7</td>
<td>$7.95</td>
<td>$8.00</td>
<td>$48.5K</td>
<td>4.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>CORZ</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$8.3</td>
<td>$8.1</td>
<td>$8.3</td>
<td>$8.00</td>
<td>$44.4K</td>
<td>4.9K</td>
<td>72</td>
</tr>
</tbody>
</table>

<h3>About Core Scientific</h3>
Core Scientific Inc is engaged in Blockchain and AI Infrastructure, Digital Asset Self-Mining, Premium Hosting, Blockchain Technology, and Artificial Intelligence related services. The business operates in two segments being; Equipment Sales and Hosting which consists of blockchain infrastructure, third-party hosting business and equipment sales to customers. Mining segment consists of digital asset mining for its account. The blockchain business generates revenue from the sale of consumption-based contracts and by providing hosting services. The digital asset mining segment earns revenue from operating a firm's owned computer equipment as part of a pool of users that process transactions conducted on one or more blockchain networks. In exchange, it receives digital currency assets.
After a thorough review of the options trading surrounding Core Scientific, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Core Scientific's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 5,108,950, the CORZ's price is up by 3.31%, now at $14.05. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 56 days.</li>
</ul>
<h3>What Analysts Are Saying About Core Scientific</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $20.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from BTIG continues to hold a Buy rating for Core Scientific, targeting a price of $20. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Core Scientific, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Core Scientific, Inc. - Class A Common Stock

CORZ

Smart Money Is Betting Big In CORZ Options

Deep-pocketed investors have adopted a bearish approach towards Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SHEL usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 13 extraordinary options activities for Shell. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 23% leaning bullish and 38% bearish. Among these notable options, 5 are puts, totaling $200,150, and 8 are calls, amounting to $359,646.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $65.0 to $72.5 for Shell during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Shell's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Shell's whale activity within a strike price range from $65.0 to $72.5 in the last 30 days. 
<h3>Shell 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1736884827_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>SHEL</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$2.65</td>
<td>$2.6</td>
<td>$2.6</td>
<td>$65.00</td>
<td>$82.6K</td>
<td>1.7K</td>
<td>0</td>
</tr>
<tr>
<td>SHEL</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$0.45</td>
<td>$0.4</td>
<td>$0.4</td>
<td>$66.00</td>
<td>$68.0K</td>
<td>4.3K</td>
<td>808</td>
</tr>
<tr>
<td>SHEL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$2.0</td>
<td>$1.75</td>
<td>$1.8</td>
<td>$70.00</td>
<td>$54.1K</td>
<td>1.7K</td>
<td>1.2K</td>
</tr>
<tr>
<td>SHEL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$2.0</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$70.00</td>
<td>$53.8K</td>
<td>1.7K</td>
<td>661</td>
</tr>
<tr>
<td>SHEL</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$1.95</td>
<td>$1.8</td>
<td>$1.8</td>
<td>$70.00</td>
<td>$48.7K</td>
<td>1.7K</td>
<td>1.8K</td>
</tr>
</tbody>
</table>

<h3>About Shell</h3>
Shell is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, it produced 1.5 million barrels of liquids and 7.3 billion cubic feet of natural gas per day. At end-2023, reserves stood at 9.6 billion barrels of oil equivalent, 49% of which, consisted of liquids. Its production and reserves are in Europe, Asia, Oceania, Africa, and North and South America. The company operates refineries with capacity of 1.6 mmb/d located in the Americas, Asia, Africa, and Europe and sells about 12 million tons per year of chemicals. Its largest chemical plants, often integrated with its local refineries, are in Central Europe, China, Singapore, and North America.
<h3>Shell's Current Market Status</h3>
<ul>
<li>With a volume of 2,745,244, the price of SHEL is up 1.49% at $65.93. </li>
<li>RSI indicators hint that the underlying stock may be overbought.</li>
<li>Next earnings are expected to be released in 16 days.</li>
</ul>
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Shell, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

SHEL

Shell Unusual Options Activity For January 14

In the last three months, 5 analysts have published ratings on Oshkosh (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSK#NYSE">OSK</a>), offering a diverse range of perspectives from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Oshkosh and provided 12-month price targets. The average target is $125.2, accompanied by a high estimate of $160.00 and a low estimate of $110.00. Highlighting a 5.58% decrease, the current average has fallen from the previous average price target of $132.60. 
<img src="https://www.benzinga.com/files/images/story/2025/1736884827_0_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The analysis of recent analyst actions sheds light on the perception of Oshkosh by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kyle Menges</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Buy</td>
<td>$110.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Tami Zakaria</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$115.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Hold</td>
<td>$116.00</td>
<td>$113.00</td>
</tr>
<tr>
<td>Steven Fisher</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$129.00</td>
</tr>
<tr>
<td>Mircea Dobre</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$160.00</td>
<td>$171.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Oshkosh. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Oshkosh compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Oshkosh's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Oshkosh's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/OSK/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Oshkosh analyst ratings.</a>
<h2>Get to Know Oshkosh Better</h2>
Oshkosh is the top producer of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, where it is typically the market share leader in North America, or, in the case of JLG aerial work platforms, a global leader. The company had manufactured joint light tactical vehicles for the us Department of Defense. However, Oshkosh recently lost the JLTV recompete, bringing into focus its us Postal Service contract, which calls for the electrification of us postal vehicles. The company reports in three segments—access equipment (52% of revenue), defense (22%), and vocational (27%)—and generated $9.6 billion in revenue in 2023.
<h3>Financial Milestones: Oshkosh's Journey</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Revenue Growth: Oshkosh displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 9.22%. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Industrials sector.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.58%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Oshkosh's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 4.49%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Oshkosh's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 1.84% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: Oshkosh's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.37.
<h2>Analyst Ratings: What Are They?</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Breaking Down Oshkosh: 5 Analysts Share Their Views

Throughout the last three months, 11 analysts have evaluated WR Berkley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), offering a diverse set of opinions from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">4</td>
<td align="right">2</td>
<td align="right">4</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated WR Berkley and provided 12-month price targets. The average target is $64.82, accompanied by a high estimate of $76.00 and a low estimate of $50.00. Surpassing the previous average price target of $62.67, the current average has increased by 3.43%.
<img src="https://www.benzinga.com/files/images/story/2025/1736884815_0.png" alt="price target chart" />
<h2>Investigating Analyst Ratings: An Elaborate Study</h2>
A comprehensive examination of how financial experts perceive WR Berkley is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$67.00</td>
<td>$68.00</td>
</tr>
<tr>
<td>Alex Scott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Underweight</td>
<td>$50.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Bob Huang</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$65.00</td>
<td>-</td>
</tr>
<tr>
<td>Robert Cox</td>
<td>Goldman Sachs</td>
<td>Announces</td>
<td>Buy</td>
<td>$69.00</td>
<td>-</td>
</tr>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$76.00</td>
<td>$73.00</td>
</tr>
<tr>
<td>Elyse Greenspan</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$68.00</td>
<td>$63.00</td>
</tr>
<tr>
<td>Brian Meredith</td>
<td>UBS</td>
<td>Raises</td>
<td>Buy</td>
<td>$69.00</td>
<td>$67.00</td>
</tr>
<tr>
<td>Scott Heleniak</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Sector Perform</td>
<td>$63.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Meyer Shields</td>
<td>Keefe, Bruyette &amp; Woods</td>
<td>Lowers</td>
<td>Market Perform</td>
<td>$58.00</td>
<td>$59.00</td>
</tr>
<tr>
<td>David Motemaden</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>In-Line</td>
<td>$60.00</td>
<td>$57.00</td>
</tr>
<tr>
<td>Mark Hughes</td>
<td>Truist Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$68.00</td>
<td>$64.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to WR Berkley. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of WR Berkley compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for WR Berkley's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of WR Berkley's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/WRB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on WR Berkley analyst ratings.</a>
<h2>Get to Know WR Berkley Better</h2>
W.R. Berkley is an insurance holding company with a host of subsidiaries that primarily underwrite commercial casualty insurance. The firm specializes in niche products that include various excess and surplus lines, workers' compensation insurance, self-insurance consulting, reinsurance, and regional commercial lines for small and midsize businesses.
<h3>Breaking Down WR Berkley's Financial Performance</h3>
Market Capitalization: Exceeding industry standards, the company's market capitalization places it above industry average in size relative to peers. This emphasizes its significant scale and robust market position.
Revenue Growth: WR Berkley's remarkable performance in 3 months is evident. As of 30 September, 2024, the company achieved an impressive revenue growth rate of 10.57%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: WR Berkley's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of 10.83%, the company may face hurdles in effective cost management.
Return on Equity (ROE): WR Berkley's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 4.51%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): WR Berkley's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of 0.92%, the company may face hurdles in achieving optimal financial returns.
Debt Management: WR Berkley's debt-to-equity ratio stands notably higher than the industry average, reaching 0.34. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

PCA

PCA (PCRDF) Forecast

PCA (OTC:PCRDF) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga